Cara Therapeutics (CARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CARA | BMY | AMGN | GILD | ILMN |
| Company | Cara Therapeutics | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7300 | 47.93 | 265.64 | 67.01 | 116.25 |
| High | 0.7361 | 48.41 | 265.92 | 67.02 | 119.18 |
| Low | 0.6800 | 47.62 | 262.58 | 65.90 | 115.73 |
| Last | 0.6900 | 48.30 | 262.75 | 66.16 | 116.69 |
| Change | -0.0419 | +0.46 | -1.32 | -0.77 | -1.60 |
| % Change | -5.72% | +0.96% | -0.50% | -1.15% | -1.35% |
| Volume | 363,100 | 10,917,581 | 2,082,600 | 6,440,700 | 1,810,200 |
| 20-Day Average Volume | 398,845 | 11,419,520 | 2,201,895 | 6,214,835 | 1,527,955 |
| Previous Close | 0.7319 | 47.84 | 264.07 | 66.93 | 118.29 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8213 | 50.99 | 272.96 | 70.21 | 129.39 |
| 20-Day Raw Stochastic | 17.91% | 9.92% | 0.65% | 3.10% | 3.37% |
| 20-Day Relative Strength | 42.28% | 37.48% | 36.64% | 27.91% | 35.49% |
| Weighted Alpha | -76.67 | -30.16 | +4.25 | -25.27 | -46.00 |
| Today's Opinion | 56% Sell | 72% Sell | 56% Sell | 100% Sell | 72% Sell |
| Previous Opinion | 56% Sell | 56% Sell | 56% Sell | 100% Sell | 72% Sell |
| Last Month's Opinion | 24% Sell | 24% Sell | 8% Sell | 88% Sell | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.88% since 04/11/24 | -1.67% since 04/11/24 | -2.69% since 04/11/24 | -3.63% since 04/11/24 | -10.72% since 04/11/24 |
| Low | 0.6311 on 04/16/24 | 47.62 on 04/18/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 0.8300 on 04/12/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.62 on 04/12/24 | 134.85 on 04/12/24 |
| 1-Month | |||||
| %Chg | -23.96% since 03/18/24 | -6.38% since 03/18/24 | -3.01% since 03/18/24 | -9.69% since 03/18/24 | -10.34% since 03/18/24 |
| Low | 0.6311 on 04/16/24 | 47.62 on 04/18/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 0.9600 on 03/28/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 144.19 on 03/21/24 |
| 3-Month | |||||
| %Chg | +26.88% since 01/18/24 | -3.57% since 01/18/24 | -13.71% since 01/18/24 | -23.43% since 01/18/24 | -13.07% since 01/18/24 |
| Low | 0.5000 on 01/25/24 | 47.58 on 02/06/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 1.1500 on 03/04/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | -51.06% since 10/18/23 | -15.04% since 10/18/23 | -7.35% since 10/18/23 | -16.96% since 10/18/23 | -6.24% since 10/18/23 |
| Low | 0.5000 on 01/25/24 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.00 on 11/10/23 |
| High | 1.4068 on 10/19/23 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 40,003 | 96,960,152 | 141,520,144 | 83,333,008 | 18,838,276 |
| Shares Outstanding, K | 54,656 | 2,026,759 | 535,919 | 1,245,077 | 159,255 |
| Annual Sales | 20,970,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | -118,510,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 3,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -32,340,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | -176,000,000 |
| 60-Month Beta | 0.70 | 0.39 | 0.58 | 0.19 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 03/04/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/20/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.43 | 14.24 | 10.02 | 135.28 |